Preclinical evaluation of Zanthoxylum piperitum Benn., traditional muscle pain remedy, for joint inflammation. (25th March 2022)
- Record Type:
- Journal Article
- Title:
- Preclinical evaluation of Zanthoxylum piperitum Benn., traditional muscle pain remedy, for joint inflammation. (25th March 2022)
- Main Title:
- Preclinical evaluation of Zanthoxylum piperitum Benn., traditional muscle pain remedy, for joint inflammation
- Authors:
- Yun, Seung-Won
Seo, Young-Jin
Kwon, Jeong Eun
Park, Dae Won
Lee, Yeong-Geun
Choe, Tae Hwan
Kim, Seul-Ki
Lee, Hak Sung
Kim, Hyunggun
Kang, Se Chan - Abstract:
- Abstract: Ethnopharmacological relevance: Zanthoxylum piperitum has been used as a traditional Asian medicine to treat hypertension, stroke, bruise and muscle pain. It has been known to induce detoxification; affect anti-bacterial, anti-oxidant, and tyrosinase activity; inhibit osteosarcoma proliferation; anti-osteoarthritis inflammation. In this study, we aim to identify the therapeutic effect of Z. piperitum 90% EtOH extract (ZPE-LR) on rheumatoid arthritis. Material and methods: We investigated the anti-rheumatoid arthritis and -immunomodulatory activities of the ZPE-LR in collagen-induced arthritic (CIA) mice, a rheumatoid arthritis animal model. In order to assess the analgesic effects of ZPE-LR in vivo, acetic acid injection, formaldehyde injection, hot plate model was used. The mechanism for anti-inflammatory activity of ZPE-LR was identified with LPS-stimulated Raw 264.7 cells. Results: Pharmacologically, oral administration of ZPE-LR into CIA mice resulted in a significant and dose-dependent decrease in clinical arthritis score and paw swelling compared to untreated negative control. Pathologic examination showed that ZPE-LR prevented morphological change in cartilage and destruction of phalanges in CIA mice. This protective effect was associated with reduced pain, inflammatory mediators such as NO, TNF-α, IL-1β, and IL-6, as well as COX-2 and iNOS expression. Furthermore, reduction of phosphor-ERK and BDNF indicates a novel rheumatoid arthritis-regulating mechanismAbstract: Ethnopharmacological relevance: Zanthoxylum piperitum has been used as a traditional Asian medicine to treat hypertension, stroke, bruise and muscle pain. It has been known to induce detoxification; affect anti-bacterial, anti-oxidant, and tyrosinase activity; inhibit osteosarcoma proliferation; anti-osteoarthritis inflammation. In this study, we aim to identify the therapeutic effect of Z. piperitum 90% EtOH extract (ZPE-LR) on rheumatoid arthritis. Material and methods: We investigated the anti-rheumatoid arthritis and -immunomodulatory activities of the ZPE-LR in collagen-induced arthritic (CIA) mice, a rheumatoid arthritis animal model. In order to assess the analgesic effects of ZPE-LR in vivo, acetic acid injection, formaldehyde injection, hot plate model was used. The mechanism for anti-inflammatory activity of ZPE-LR was identified with LPS-stimulated Raw 264.7 cells. Results: Pharmacologically, oral administration of ZPE-LR into CIA mice resulted in a significant and dose-dependent decrease in clinical arthritis score and paw swelling compared to untreated negative control. Pathologic examination showed that ZPE-LR prevented morphological change in cartilage and destruction of phalanges in CIA mice. This protective effect was associated with reduced pain, inflammatory mediators such as NO, TNF-α, IL-1β, and IL-6, as well as COX-2 and iNOS expression. Furthermore, reduction of phosphor-ERK and BDNF indicates a novel rheumatoid arthritis-regulating mechanism by ZPE-LR treatment. Conclusions: These data suggest that the administration of ZPE-LR remarkably inhibited CIA progression and might be helpful in suppressing inflammation and pain in rheumatoid arthritis. Graphical abstract: Image 1 Highlights: ZPE-LR have been effectively inhibited on rheumatoid arthritis-induced pain and inflammation. ZPE-LR prevented morphological change in cartilage and destruction of phalanges in CIA mice on pathologic examination. … (more)
- Is Part Of:
- Journal of ethnopharmacology. Volume 286(2022)
- Journal:
- Journal of ethnopharmacology
- Issue:
- Volume 286(2022)
- Issue Display:
- Volume 286, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 286
- Issue:
- 2022
- Issue Sort Value:
- 2022-0286-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-03-25
- Subjects:
- BDNF -- Collagen-induced arthritis -- COX-2 -- Phosphor-ERK -- iNOS -- Zanthoxylum piperitum
IκBα inhibitor of NF-κB -- NF-κB nuclear factor κB -- ROS Reactive oxygen species -- MAPKs Mitogen-activated protein kinases -- Ubr4 Ubiquitin Protein Ligase E3 Component N-Recognin 4 -- BDNF Brain-derived neurotrophic factor -- DMARDs disease-modifying anti-rheumatic drugs -- ZPE-LR Zanthoxylum piperitum 90% EtOH extract -- s.c subcutaneous -- RT-PCR reverse transcription polymerase chain reaction -- TBST Tris-buffered saline containing 0.05% Tween-20 -- PBST phosphate-buffered saline containing 0.1% Tween-20 -- ACP annealing control primer -- SEM standard error of the mean
Ethnopharmacology -- Periodicals
Pharmacognosy -- Periodicals
Herbs -- Periodicals
Herbs -- Periodicals
Pharmacognosy -- Periodicals
Pharmacognosie -- Périodiques
Herbes -- Périodiques
615.1 - Journal URLs:
- http://www.sciencedirect.com/science/journal/03788741 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.jep.2021.114921 ↗
- Languages:
- English
- ISSNs:
- 0378-8741
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4979.602400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20493.xml